EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry

Vincenzo Arcoraci, Michelangelo Rottura, Viviana Maria Gianguzzo, Giovanni Pallio, Egidio Imbalzano, Alessandro Nobili, Giuseppe Natoli, Christiano Argano, Giovanni Squadrito, Natasha Irrera, Salvatore Corrao, REPOSI investigators

Archives of Gerontology and Geriatrics · 2025

DOI: 10.1016/j.archger.2024.105602 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Archives of Gerontology and Geriatrics, 2025. Verfasst von Vincenzo Arcoraci und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Registries, Hospitalization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) prevalence increases in older patients which also show a high thromboembolic risk. Oral anticoagulants (OACs) are recommended to prevent cardioembolic events and direct oral anticoagulants (DOACs) improved anti-thrombotic treatment. However, the benefits/risks of anticoagulant in older patients still need to be completely defined. This retrospective observational study aimed to describe the treatment with OACs in older AF hospitalized patients, and to identify factors influencing OAC therapy or discontinuation using the REgistro Politerapie SIMI. Univariate and multivariate logistic regression models were applied to identify predictors of OACs treatment and discontinuation. Cox proportional hazards models were performed to evaluate one-year mortality by treatment groups. AF patients were 1,128(26.5 %) at discharge and 1,098(97.3 %) required OAC treatment; about half of them (N = 528;48.1 %) were no-OACs users; 236(21.5 %) and 334(30.4 %) used DOACs and VKA, respectively. Increasing DOACs use was observed during the study period. Predictors of OACs treatment were: BMI (OR:1.04; 95 %CI:1.01-1.07), Barthel index (OR:1.01; 95 %CI:1.01-1.02), medications number (OR:1.07; 95 %CI:1.01-1.13). Conversely, a lower probability was found in patients with a high CIR.S (OR:0.59; 95 %CI:0.36-0.97) and neoplasm (OR:0.57; 95 %CI:0.37-0.88). Hospital stay (OR:1.02; 95 %CI:1.01-1.05), neoplasm (OR:2.25; 95 %CI:1.07-4.70) and INR (OR:1.21; 95 %CI:1.05-1.40) increased OACs discontinuation. A lower discontinuation was observed in dyslipidemic patients (OR:0.18; 95 %CI:0.04-0.82) and heart failure (OR:0.38; 95 %CI:0.21-0.70). Among AF patients, 157(14.3 %) died during the follow-up year. Age (HR = 1.05; 95 %CI = 1.03-1.08) and CIR.S (HR = 2.54; 95 %CI = 1.53-4.21) were associated with a greater mortality risk. In conclusion, critical issues related to the underuse and discontinuation of OACs therapy in hospitalized older patients were highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsRegistriesHospitalizationHumansMaleFemaleRetrospective StudiesItalyAged, 80 and overAdministration, OralAgedPractice Patterns, Physicians'

Stichwörter der Autor:innen

Anticoagulant treatmentAtrial fibrillationDOACsOlder patientsREPOSI registerUnder prescribing

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
  • Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy.
  • Department of Neuroscience, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Dipartimento di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", PROMISE, University of Palermo, Palermo, Italy.
  • Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Electronic address: nirrera@unime.it.

Zitieren

APA

Arcoraci, V., Rottura, M., Gianguzzo, V. M., Pallio, G., Imbalzano, E., Nobili, A., Natoli, G., Argano, C., Squadrito, G., Irrera, N., Corrao, S., & REPOSI investigators (2025). Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry. Archives of Gerontology and Geriatrics. https://doi.org/10.1016/j.archger.2024.105602

Vancouver

Arcoraci V, Rottura M, Gianguzzo VM, Pallio G, Imbalzano E, Nobili A, et al. Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry. Archives of Gerontology and Geriatrics. 2025. doi:10.1016/j.archger.2024.105602

BibTeX
@article{Arcoraci2025,
  author = {Arcoraci, Vincenzo and Rottura, Michelangelo and Gianguzzo, Viviana Maria and Pallio, Giovanni and Imbalzano, Egidio and Nobili, Alessandro and Natoli, Giuseppe and Argano, Christiano and Squadrito, Giovanni and Irrera, Natasha and Corrao, Salvatore and REPOSI investigators, REPOSI investigators},
  title = {Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry},
  journal = {Archives of Gerontology and Geriatrics},
  year = {2025},
  doi = {10.1016/j.archger.2024.105602}
}
Kostenlos starten →